Saturday 17 October 2026
Export EHC’s income statement to Excel — free account
Encompass Health Corporation
EHC Healthcare Medical Care Facilities
Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.58%, EPS grew 9.93%, free cash flow fell 45.0% and total debt rose 7.09%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.
127.87
0.10
+0.08%
Follow EHC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
18.85 | 20.30 | 19.13 | 21.94 | 12.51 | 22.92 | 15.10 | 16.53 | 14.92 | 11.95 |
Piotroski F-Score |
7 | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 6 | 7 |
Altman Z-Score |
3.25 | 2.92 | 2.35 | 2.13 | 1.64 | 1.68 | 1.75 | 1.78 | 1.58 | 1.32 |
P/S ratio |
1.80 | 1.72 | 1.39 | 1.36 | 1.28 | 1.82 | 1.17 | 1.12 | 0.98 | 0.81 |
P/FCF ratio |
26.04 | 27.90 | 28.07 | 64.04 | 36.35 | 23.53 | 24.35 | 9.77 | 9.27 | 6.39 |
Altman Z″-Score (non-manufacturers) |
2.53 | 2.12 | 1.84 | 1.49 | 1.43 | 1.12 | 0.92 | 0.70 | 0.77 | 0.43 |
P/Operating CF |
30.83 | 33.09 | 33.25 | 34.25 | 41.52 | 23.19 | 25.05 | 26.94 | 25.30 | 20.94 |
Beneish M-Score |
(2.71) | (2.76) | (2.66) | (2.86) | (2.75) | (2.57) | (2.55) | (2.81) | (2.68) | (2.73) |
Dividend Safety Score |
77 | — | — | — | — | — | — | — | — | — |
P/B ratio |
3.32 | 3.30 | 2.96 | 3.23 | 2.18 | 3.29 | 3.19 | 3.09 | 2.75 | 3.17 |
Price to Tangible BV |
6.70 | 7.62 | 9.61 | 21.01 | 5.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.20 | 2.16 | 1.94 | 1.98 | 2.07 | 2.66 | 1.80 | 1.68 | 1.61 | 1.61 |
EV/EBITDA |
9.39 | 9.89 | 9.15 | 9.75 | 9.38 | 12.90 | 9.15 | 8.63 | 7.57 | 7.02 |
EV/Operating CF |
11.10 | 11.57 | 10.92 | 12.20 | 11.60 | 13.46 | 13.08 | 9.43 | 9.56 | 9.16 |
EV/FCF |
31.87 | 35.08 | 39.02 | 93.51 | 58.74 | 34.40 | 37.47 | 14.62 | 15.22 | 12.71 |
Quick Ratio |
0.86 | 0.86 | 1.09 | 1.02 | 0.84 | 1.20 | 0.91 | 0.89 | 1.14 | 1.15 |
Current Ratio |
1.08 | 1.05 | 1.28 | 1.25 | 1.23 | 1.32 | 1.05 | 0.98 | 1.36 | 1.38 |
Net Debt/EBITDA |
1.72 | 2.02 | 2.57 | 3.07 | 3.57 | 4.08 | 3.21 | 2.86 | 2.96 | 3.49 |
Debt/Assets |
35.13% | 38.22% | 44.45% | 49.09% | 47.75% | 51.02% | 50.37% | 48.59% | 52.99% | 64.43% |
Debt/Equity |
0.77 | 0.89 | 1.20 | 1.52 | 1.39 | 1.67 | 1.81 | 1.61 | 1.85 | 3.25 |
Asset Turnover |
0.87 | 0.85 | 0.82 | 0.70 | 0.60 | 0.57 | 0.82 | 0.85 | 0.82 | 0.78 |
Operating CF/Net income |
2.08 | 2.20 | 2.42 | 2.60 | 1.74 | 2.48 | 1.77 | 2.61 | 2.43 | 2.59 |
Capex/Depreciation |
(2.18) | (2.08) | (2.06) | (2.35) | (2.43) | (1.92) | (1.81) | (1.36) | (1.29) | (0.96) |
Interest Coverage |
8.55 | 6.29 | 5.10 | 3.59 | 4.01 | 2.86 | 4.29 | 4.27 | 4.14 | 3.77 |
| 18.84% | 18.06% | 17.25% | 12.96% | 19.05% | 15.52% | 22.07% | 19.80% | 23.33% | 28.99% | |
| 8.31% | 7.21% | 6.00% | 4.34% | 6.19% | 4.54% | 6.37% | 5.82% | 5.68% | 5.33% | |
ROIC |
11.74% | 10.45% | 9.40% | 8.68% | 7.45% | 6.61% | 9.30% | 9.98% | 10.35% | 10.55% |
Return on Tangible Assets |
13.57% | 12.35% | 10.10% | 8.80% | 14.97% | 11.66% | 17.99% | 17.99% | 15.93% | 15.76% |
Average Days of Receivables |
38.08 | 40.68 | 46.50 | 45.06 | 46.89 | 58.62 | 40.11 | 39.91 | 44.03 | 44.47 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
60.76% | 62.33% | 62.90% | 63.23% | 61.79% | 62.43% | 64.88% | 63.89% | 63.25% | 62.02% |
Intangible Assets out of Total Assets |
0.23 | 0.24 | 0.26 | 0.27 | 0.20 | 0.43 | 0.46 | 0.49 | 0.49 | 0.50 |
Share Based Compensation of Revenue |
0.95% | 0.90% | 1.05% | 0.67% | 0.72% | 0.72% | 2.48% | 2.01% | 1.22% | 0.75% |
Graham Net Nets |
(0.28) | (0.31) | (0.45) | (0.52) | (0.70) | (0.54) | (0.67) | (0.62) | (0.72) | (1.05) |
Graham Number |
63.68 | 53.50 | 42.31 | 33.50 | 47.15 | 35.92 | 37.67 | 32.60 | 30.30 | 25.49 |
Earnings Yield |
5.30% | 4.93% | 5.23% | 4.56% | 7.99% | 4.36% | 6.62% | 6.05% | 6.70% | 8.37% |
Free Cash Flow Yield |
3.84% | 3.58% | 3.56% | 1.56% | 2.75% | 4.25% | 4.11% | 10.24% | 10.79% | 15.64% |
Revenue per Share |
59.06 | 53.79 | 48.25 | 43.84 | 40.55 | 36.17 | 46.99 | 43.69 | 41.77 | 40.88 |
Operating CF per Share |
11.70 | 10.04 | 8.55 | 7.11 | 7.23 | 7.15 | 6.48 | 7.79 | 7.03 | 7.19 |
Capex per Share |
(7.33) | (6.43) | (5.86) | (5.99) | (5.58) | (4.10) | (4.12) | (2.82) | (2.65) | (2.01) |
Free Cash Flow per Share |
4.37 | 3.61 | 2.69 | 1.13 | 1.65 | 3.04 | 2.36 | 4.97 | 4.37 | 5.18 |
Cash per Share |
1.02 | 1.23 | 1.05 | 0.54 | 1.13 | 2.94 | 1.55 | 1.31 | 1.25 | 1.14 |
Shareholders Equity per Share |
32.01 | 27.96 | 22.67 | 18.41 | 23.81 | 19.98 | 17.28 | 15.90 | 14.89 | 10.42 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
32.01 | 27.96 | 22.67 | 18.41 | 23.81 | 19.98 | 17.28 | 15.90 | 14.89 | 10.42 |
Free Cash Flow |
439.20 | 360.30 | 267.70 | 111.60 | 163.60 | 300.10 | 231.20 | 486.20 | 409.60 | 461.20 |
Working Capital |
69.50 | 45.90 | 185.40 | 141.30 | 172.60 | 231.30 | 34.80 | (10.40) | 184.70 | 178.90 |
Capital Expenditures |
(736.40) | (642.50) | (583.10) | (594.20) | (552.20) | (404.60) | (404.10) | (276.20) | (248.70) | (179.00) |
Net Current Asset Value |
(2,966.30) | (2,855.10) | (3,005.40) | (3,093.00) | (3,586.50) | (3,527.30) | (3,631.80) | (2,955.90) | (2,766.90) | (3,098.70) |
EV/EBIT |
12.40 | 13.43 | 12.70 | 13.67 | 12.62 | 18.06 | 12.14 | 11.42 | 9.85 | 9.04 |
Capex to Sales |
0.12 | 0.12 | 0.12 | 0.14 | 0.14 | 0.11 | 0.09 | 0.06 | 0.06 | 0.05 |
Price to Operating Income |
10.13 | 10.68 | 9.13 | 9.36 | 7.81 | 12.35 | 7.89 | 7.63 | 6.00 | 4.54 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 | 0.13 |
Cash ROIC |
7.56% | 6.66% | 5.28% | 2.40% | 2.85% | 5.41% | 4.71% | 11.58% | 10.01% | 11.40% |
Accounts Receivable Turnover |
9.75 | 8.88 | 8.36 | 8.26 | 7.38 | 6.61 | 9.46 | 9.10 | 8.55 | 8.53 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
609.00 | 605.20 | 574.20 | 526.30 | 544.30 | 539.45 | 486.90 | 469.90 | 457.95 | 427.15 |
Average Payables |
174.60 | 170.50 | 151.45 | 133.45 | 124.50 | 104.80 | 92.30 | 84.20 | 73.35 | 64.95 |
Average Assets |
6,812.20 | 6,318.55 | 5,869.45 | 6,250.70 | 6,655.40 | 6,263.30 | 5,627.85 | 5,019.75 | 4,773.20 | 4,644.00 |
Average Common Equity |
3,005.10 | 2,523.95 | 2,040.75 | 2,091.65 | 2,163.50 | 1,831.55 | 1,625.05 | 1,476.20 | 1,162.05 | 854.00 |
Columns are period end dates